Vericel (VCEL) Competitor Comparison
We are evaluating the key criteria listed to compare Vericel (VCEL) against its competitors in the Biotechnology industry.
Market Capitalization
74 / 368Gross Profits
43 / 278Total Revenue
62 / 300EBITDA
52 / 337Free Cashflow
88 / 352Quick Ratio
216 / 357Earnings per Share
38 / 359Dividend yield
0 / 6Total Cash
208 / 358Performance 3 years
86 / 368Performance 5 years
53 / 368Performance 10 years
5 / 368Linearity 3 years
61 / 368Linearity 5 years
313 / 368Linearity 10 years
362 / 368Total Rank
55 / 368Dividend Rank
301 / 368Valuation Rank
296 / 368Piotroski Rank
216 / 368Muliplier Rank
228 / 368Market Capitalization - VCEL ranking 74 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.